Gerd & Nerd Treatment Market Information, By Drug Class, Dosage Form, End User - Americas Forecast Till 2023
Americas GERD & NERD treatment market is anticipated to grow at the CAGR of 4.02% during the forecast period 2017-2023.
Gerd & Nerd Treatment Market Information, By Drug Class (Antacids (Acid Neutralizers), Proton Pump Inhibitors, H2 Receptor Blocker), Dosage Form (Solid and Liquid), End User (Hospitals & Clinics, Research Centers, And Others) - Americas Forecast Till 2023
In the course of the last two hundred years, indigestion has been one of the common health issues in the U.S. However, a definitive objective of the gastroesophageal reflux treatment has dependably continued as before, which is to stifle the side effects of the GERD patient. GERD influences up to 40% of the U.S. populace in their lifetime and currently, most of the people are facing this health condition. If the GERD isn't appropriately overseen, it can prompt Barrett's esophagus. Early treatment of Barrett's esophagus is significant in light of the fact that it is the essential risk factor for esophageal cancer. The frequency of indigestion issue, otherwise called acid reflux, is quickly expanding around the world. According to various studies almost each individual experiences acid reflux at least once in their lifetime. GERD is one of the regularly watched intermittent gastrointestinal disorders around the world. The Americas GERD & NERD treatment market is anticipated to grow at the CAGR of 4.02% during the forecast period 2017-2023.
This issue not just affects the health and nature of patient lives yet, in addition, stretches out to the healthcare economy and system.
The real driving elements for the development of the market are expanding instances of smoking, rising instances of reflux issue amid pregnancy, evolving way of life, and sporadic dietary propensities. In addition, expanding occurrence of indigestion issue (acid reflux), developing geriatric populace is probably going to fuel the market development.
The Americas GERD & NERD treatment market is classified on the basis of its drug class, end user, dosage form, and regional analysis.
Based on its drug class, the market is bifurcated into proton pump inhibitors, antacids (acid neutralizers), H2 receptor blocker, antidepressants, prokinetic agents, calcium channel blockers, among others. On the basis of its dosage form, the Americas GERD & NERD treatment market is divided into liquid and solid. Based on its end-user industry, the global market is segmented into research centers, hospitals & clinics, and others.
Geographically, the Americas GERD & NERD treatment market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.
The list of major players in the Americas GERD & NERD treatment market include companies like AstraZeneca Plc (U.K), Cempra Inc. (U.S.), Boston Scientific Corporation (U.S.), Eisai Co., Ltd. (Japan), EndoStim Inc. (U.S.), EndoGastric Solutions Inc. (U.S.), GlaxoSmithKline Plc (U.K), Jeil Pharmaceutical Co. Ltd. (South Korea), Ironwood Pharmaceuticals, Inc. (U.S.), Johnson & Johnson (U.S.), Medigus Ltd. (Israel), Mederi Therapeutics Inc. (U.S.), Medtronic Inc. (U.S.), Valeant Pharmaceuticals International, Inc. (Canada), Allegiant health (U.S.), Tya pharmaceuticals (U.S.), among others.